Detalhe da pesquisa
1.
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
N Engl J Med
; 380(20): 1906-1917, 2019 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31091372
2.
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.
Blood
; 135(7): 491-504, 2020 02 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31805182
3.
Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery: A Subanalysis of the RE-VERSE AD Study.
Ann Surg
; 274(3): e204-e211, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31599808
4.
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.
N Engl J Med
; 377(5): 431-441, 2017 08 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28693366
5.
Idarucizumab for Dabigatran Reversal.
N Engl J Med
; 373(6): 511-20, 2015 Aug 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26095746
6.
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
J Thromb Thrombolysis
; 43(4): 484-489, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28210989
7.
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.
Eur Heart J
; 37(9): 747-54, 2016 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26077039
8.
Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
Lancet
; 386(9994): 680-90, 2015 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26088268
9.
Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials.
Thromb J
; 13: 36, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26578849
10.
Reduction of right ventricular pacing with advanced atrioventricular search hysteresis: results of the PREVENT study.
Pacing Clin Electrophysiol
; 34(8): 975-83, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21438891
11.
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.
Lancet Haematol
; 8(1): e22-e33, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33290737
12.
Dosing Recommendations for New Oral Anticoagulants.
JAMA
; 313(24): 2496, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26103039
13.
The nucleotide analogue 3-deazaadenosine prevents neointima-formation after balloon injury.
Biochem Biophys Res Commun
; 378(4): 826-31, 2009 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-19070587
14.
Interleukin-10 suppresses tissue factor expression in lipopolysaccharide-stimulated macrophages via inhibition of Egr-1 and a serum response element/MEK-ERK1/2 pathway.
Circ Res
; 97(4): 305-13, 2005 Aug 19.
Artigo
Inglês
| MEDLINE | ID: mdl-16037570
15.
Activation of inwardly rectifying Kir2.x potassium channels by beta 3-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2.
Naunyn Schmiedebergs Arch Pharmacol
; 375(5): 311-22, 2007 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-17534603
16.
Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656.
Nutr Metab Cardiovasc Dis
; 17(9): 666-75, 2007 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-16926094
17.
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II.
Thromb Haemost
; 117(11): 2045-2052, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29202209
18.
Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study.
Clin Pharmacokinet
; 56(1): 41-54, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27317414
19.
Electronic health records to facilitate clinical research.
Clin Res Cardiol
; 106(1): 1-9, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27557678
20.
Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.
Naunyn Schmiedebergs Arch Pharmacol
; 373(3): 212-20, 2006 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-16736158